Compound

D1013 | nelfinavir mesylate

Molecular Formula C33H49N3O7S2
Molecular Weight 663.9
Structure

Toxicity Dose Time Species Model Method Action Positive criterion Reference
MEMBRANE POTENTIAL 11.88±6.92 human qHTS-HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 30.83 human HepG2 MMP assay decrease IC50 163
MEMBRANE POTENTIAL 8.68±12.24 rat hepatocytes MMP assay decrease IC50 163

Pictogram Signal Statements Precautionary Statement Codes

Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory.


H413 (100%): May cause long lasting harmful effects to aquatic life [Hazardous to the aquatic environment, long-term hazard]


Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.


P273, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.)

Organism Test type Route Dose (normalized dose) Effect Source
rat LD oral > 5gm/kg (5000mg/kg) Toxicologist. Vol. 42, Pg. 55, 1998.


  • (3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroiso-quinoline-3-carboxylic acid t-butylamide methanesulfonate (3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide methanesulfonate (3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide methanesulfonate
    (3S,4aS,8aS)-3-(tert-butylcarbamoyl)-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinolinium methanesulfonate (3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2- hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide methanesulfonate (3S,4aS,8aS)-N-tert-Butyl-2-((2R,3R)-3-(3,2-cresotamido)-2-hydroxy-4-(phenylthio)butyl)decahydro-3-isoquinolinecarboxamide monomethanesulfonate (salt)
    (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide methanesulfonate (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]decahydroisoquinoline-3-carboxamide methanesulfonate (salt) 159989-65-8
    3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-, monomethanesulfonate (salt) 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2(2,S*,3S*),3-alpha,4a-beta,8a-beta))-, monomethanesulfonate (salt) 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, methanesulfonate (1:1)
    3-Isoquinolinecarboxamide,1-dimethylethyl)decahydro-2- [(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, methanesulfonate (3S,4aS,8aS)-; 3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide methanesulfonate 989N658
    98D603VP8V AC-20033 AG 1341
    AG 1343 AG 1343 Mesylate AG-1343
    AG-1346 AG1343 AKOS015963185
    ARV-SR0121 AZT/3TC/NLFR combination C08091
    C32H45N3O4S.CH4O3S C33H49N3O7S2 CAS-159989-65-8
    CCG-100925 CHEBI:7497 CHEMBL1205
    CPD000469186 CTK8E9065 D00899
    DSSTox_CID_10777 DSSTox_GSID_33736 DSSTox_RID_79093
    DTXSID2033736 HMS2051N05 HMS2090L17
    HMS2233M20 HMS3261P12 HMS3715B04
    HSDB 7159 J-009662 KS-1089
    LS-85416 LY-312857 MFCD00931436
    MLS001055355 MLS001401378 MLS006010141
    N0986 NC00175 NCGC00090782-01
    NCGC00090782-03 NCGC00090782-06 NCGC00258475-01
    NCGC00261320-01 NFV NQHXCOAXSHGTIA-SKXNDZRYSA-N
    NSC-722664 NSC722664 Nelfin
    Nelfinavir (Mesylate) Nelfinavir Mesylate [USAN] Nelfinavir Methanesulfonate
    Nelfinavir mesilate Nelfinavir mesilate (JAN) Nelfinavir mesylate
    Nelfinavir mesylate (USAN/INN) Nelfinavir mesylate hydrate Nelfinavir mesylate hydrate, >=98% (HPLC)
    Nelfinavir methanesulfonate hydrate Q27107510 RT-014683
    SAM001246655 SC-79735 SCHEMBL40942
    SMR000469186 SW197555-2 SYN3022
    Tox21_111021 Tox21_111021_1 Tox21_200921
    Tox21_500635 UNII-98D603VP8V Viracept
    Viracept (TN) W-5226 nelfinavir-mesylate
    s4282

    CAS Number 159989-64-7, 159989-65-8
    PubChem Compound 64142
    KEGG Compound ID C08091
    KEGG Drug D00899
    ChEBI 7497